I. National Leading Specialized Cancer Hospitals
1. Cancer Hospital, Chinese Academy of Medical Sciences (Beijing)
- Ranked No.1 oncology specialty hospital by Fudan University for 15 consecutive years
- Home to the National Cancer Center
- Advanced “Da Vinci robot + hypofractionated radiotherapy” combined treatment
- 92% clearance rate for minimally invasive lung cancer surgery
- 63% 5-year survival rate for esophageal cancer
- Features proton therapy and full digital treatment management
- Specializes in lung cancer, breast cancer, and bone metastases treatment
2. Fuda Cancer Hospital (Guangzhou)
- Leading global volume in cryoablation (CSA), effective for complex cases such as central lung cancer, large liver tumors, and pancreatic cancer
- Equipped with automated immunohistochemistry and flow cytometry instruments for precise diagnosis and translational research
3. Fudan University Cancer Hospital (Shanghai)
- Notable precision radiotherapy using TrueBeam linear accelerator
- “NanoKnife + hyperthermic perfusion” improved pancreatic cancer 5-year survival from 6% to 31%
- Multidisciplinary team with 71.8% overall 5-year survival rate and 9.3% colorectal cancer postoperative recurrence
II. Top Specialized Hospitals by Cancer Type
Lung Cancer
- Shanghai Chest Hospital: Early adopter of lung cancer MDT model; leading global Da Vinci robotic thoracic surgeries; over 90% minimally invasive surgeries
- Cancer Hospital, CAMS: Advanced lung cancer median survival extended to 28.6 months
- Second Affiliated Hospital of University of South China: Recognized for AI-assisted diagnosis and respiratory intervention technologies
Gastrointestinal Tumors (Stomach and Colorectal Cancer)
- Peking University Cancer Hospital: 99% accuracy in D2 lymph node dissection for gastric cancer; 70% minimally invasive early gastric cancer surgeries
- Zhejiang Cancer Hospital: Over 3,000 no-abdominal-incision colorectal surgeries; patients can resume eating within 3 days post-operation
Breast Cancer
- Tianjin Medical University Cancer Institute: Leading breast-conserving and reconstructive surgeries nationwide; 39% pathological complete response rate in triple-negative breast cancer neoadjuvant therapy
- Fudan University Cancer Hospital: Breast preservation combined with intraoperative radiotherapy; suitable for tumors up to 5 cm diameter
Nasopharyngeal Carcinoma and Liver Cancer
- Sun Yat-sen University Cancer Center: 84% 5-year survival rate for nasopharyngeal carcinoma; precise proton therapy targeting liver cancer lesions
- Fuda Cancer Hospital: Mature multidisciplinary team model with cross-departmental support for complex surgeries
III. Regional Recommendations
- South China: Fuda Cancer Hospital (Guangzhou)
- East China: Fudan University Cancer Hospital or Zhejiang Cancer Hospital
- North and Northeast China: Cancer Hospital, CAMS or Peking University Cancer Hospital
IV. Cutting-edge Treatments
- Refractory Hematologic Tumors: CAR-T clinical trials at Wuhan Union Hospital
- Deep-seated Solid Tumors (e.g., pancreatic cancer): Proton and heavy ion therapy centers in Wuwei and Shanghai